Exploring Sonic Hedgehog Cell Signaling in Neurogenesis: Its Potential Role in Depressive Behavior.

Publication date: Mar 30, 2021

Depression is the most prevalent form of neuropsychiatric disorder affecting all age groups globally. As per the estimation of the World Health Organization (WHO), depression will develop into the foremost reason for disability globally by the year 2030. The primary neurobiological mechanism implicated in depression remains ambiguous; however, dysregulation of molecular and signaling transductions results in depressive disorders. Several theories have been developed to explain the pathogenesis of depression, however, none of them completely explained all aspects of depressive-pathogenesis. In the current review, we aimed to explore the role of the sonic hedgehog (Shh) signaling pathway in the development of the depressive disorder and its potential as the therapeutic target. Shh signaling has a crucial function in neurogenesis and neural tube patterning during the development of the central nervous system (CNS). Shh signaling performs a basic function in embryogenesis and hippocampal neurogenesis. Moreover, antidepressants are also known to enhance neurogenesis in the hippocampus, which further suggests the potential of Shh signaling. Furthermore, there is decreased expression of a glioma-associated oncogene (Gli1) and Smoothened (Smo) in depression. Moreover, antidepressants also regulate brain-derived neurotrophic factor (BDNF) and wingless protein (Wnt) signaling, therefore, Shh may be implicated in the pathogenesis of the depressive disorder. Deregulation of Shh signaling in CNS results in neurological disorders such as depression.

Concepts Keywords
Expression glioma
Pathogenesis depression
Branches of biology
Cell signaling
Proteins
Developmental neuroscience
Hedgehog signaling pathway
Sonic hedgehog
Sonic the Hedgehog
Brain-derived neurotrophic factor
GLI1
Major depressive disorder
Smoothened

Semantics

Type Source Name
disease MESH Depression
disease MESH depressive disorders
drug DRUGBANK Vorinostat
disease MESH development
disease MESH glioma
pathway KEGG Glioma
disease MESH neurological disorders

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *